Member Info for mulledwine

2011 Highlights Operational highlights · Record attributable gold production of 448.9 koz (up 21.6%) due to ramp-up at Soledad-Dipolos and higher throughput at Herradura · Stable silver production of 41.87Moz (including Silverstream) benefited from the start-up of Saucito · Noche Buena to commence production in March 2012 · Very strong exploration results, 23% increase in silver resources (1.8 billion oz) and 17% in gold resources (23.5Moz). · Implementation of the Safety Action Plan in response to fatalities in the year · On track to produce 65 million ounces of silver and a new target of 500,000 attributable ounces of gold annually by 2018 Financial highlights · Adjusted revenue1 up 56.6% to US$2,307.5 million · EBITDA2 up 62.8% to US$1,538.5 million (EBITDA margin of 70.2%) · Fresnillo remains in the lowest quartile of the cost curve · Profit from continuing operations up 63.3% to US$1,360.9million · Profit before interest and tax for the year of US$1,038.6 million up 39% (including a US$114.5 million of Silverstream revaluation effects) · EPS up 35.6% to US$1.257 · Robust balance sheet with no debt and a strong cash position of US$685 million · US$ 179m capital invested in exploration3 · US$423m invested in CAPEX4 · Final dividend of 40.0 US cents per ordinary share declared, bringing total dividends for 2011 to 102.85 US cents per share (2010: 44.8 US cents)

http://www.investegate.co.uk/Article.aspx?id=201203060700207363Y

Outlook Market and competitive conditions are expected to continue to be challenging. The world's financial markets remain unsettled, however, and it seems reasonable to expect that there will be some periods of market volatility and heightened activity during 2012, as well as periods of more subdued activity. The business has made a reasonable start to the year. Revenue in the first two months of 2012, at constant exchange rates and excluding the recent acquisitions of Convenção and Chapdelaine, is 1% lower than in the same period last year. Actions have been taken to reduce costs and to maintain flexibility in the cost base, although the business does face increased costs relating to electronic platform developments and impending regulatory changes. The enduring strength of the business is the valuable service it provides to clients through its ability to create liquidity through price and volume discovery to facilitate trading in a wide range of financial instruments. We agree with the objectives and support the direction of the reforms designed to strengthen the financial system and to improve the operation of the financial markets. We consider that the introduction of these reforms will be positive for our business as the proposals formalise the role of the intermediary in the OTC markets. We believe that we are well positioned to continue to provide a valuable service to clients and that our offering can be developed to meet the various new OTC market regulations that will be introduced.

Commenting on the results, Keith Hamill, Chairman of Tullett Prebon plc, said: "The financial results for 2011 demonstrate the strength of the business in challenging market and competitive conditions, and the value of the service the business provides to participants in the world's OTC financial markets. Revenue for the year of £910.2m was in line with that reported for 2010. Using constant exchange rates, and adjusting for Convenção which was acquired in August 2011, and for the satellite offices in the Americas which were closed or exited during the second half of 2010, revenue was 2% higher. As market activity in 2011 was lower overall than in 2010, this was a good performance reflecting the benefit of continued investment in the business. Underlying profit before tax of £136.1m compares with £149.0m in 2010. With a reduction in the effective rate of tax on underlying profit to 27.1%, underlying basic earnings per share were 8% lower than last year at 46.1p. The business has again generated a strong cash flow. Operating cash flow for the year was £136.8m, representing 92% of underlying operating profit, and at the end of the year net funds amounted to £107.1m, an increase in the year of £39.3m. The Board recognises that dividends are an important element of shareholder return and is recommending a final dividend of 11.25p per share, making the total dividend for the year 16.5p per share, an increase of 5% on the 15.75p per share paid for 2010. The final dividend will be payable on 17 May 2012 to shareholders on the register at close of business on 27 April 2012."

PRELIMINARY RESULTS - for the year ended 31 December 2011 Tullett Prebon plc (the "Company") today announced its preliminary results for the year ended 31 December 2011. Financial Highlights · Revenue £910.2m (2010: £908.5m) · Underlying Operating profit £148.4m (2010: £160.1m) · Underlying Operating margin 16.3% (2010: 17.6%) · Underlying Profit before tax £136.1m (2010: £149.0m) · Basic Underlying EPS 46.1p (2010: 50.1p) · Operating cash flow £136.8m - 92% conversion of underlying operating profit · Reported Profit before tax £119.2m (2010: £141.3m) · Reported Basic EPS 41.3p (2010: 50.5p)

http://www.investegate.co.uk/Article.aspx?id=201203060700217373Y

Solid figures and they are very positive about the coming year

Commenting on the results, Nigel Howard, Chairman, said: I am pleased to report our 2011 profit before tax increased by 16% to £5.47m (2010: £4.70m excluding exceptional items), which means that this profit measure has doubled in the last five years, equating to a compound annual growth rate of 15%. Moreover, we have achieved this whilst maintaining a strong balance sheet, with net funds of £1.92m at the end of 2011 (2010: net funds of £1.86m). We begin 2012 with a strong order book for both Azote® polyolefin foams and our portfolio of HPP products. Following on from a record sales year in 2011, orders for Azote® foams for the first quarter are well ahead of the comparable period last year. The outlook for our HPP foams is even more promising with confirmed orders for 2012 already ahead of HPP sales in 2011. We are of course influenced by global economic factors as well as the uncertainty associated with developing new products and markets. However, we enter 2012 with an exceptionally strong order book, a robust cash position, and the benefits of our considerable investments made in people and products in recent years. The Board is therefore very confident about the prospects for our business and expects 2012 to be another year of further progress.

Continued sales and profit growth Zotefoams plc ("Zotefoams", or "the Group" or "the Company"), the world leader in cellular material technology, today announces its preliminary results for the 12 months ended 31 December 2011. HIGHLIGHTS 2011 • Profit before tax and exceptional items up 16% to £5.47m (2010: £4.70m) • Basic earnings per share excluding exceptional items up 16% to 11.8p (2010: 10.2p) ¹ • Revenue up 11% to £44.21m (2010: £39.88m) • Ownership of MuCell Extrusion LLC ("MEL") increased to 100% • Successful placement of 1.5m shares (additional 4% of share capital) at 150p per share in March 2011 • Net cash of £1.92 million (31/12/10: £1.86m) ² • 5% increase in proposed final dividend to 3.30p per share (2010: 3.15p)³ 2012 • Strong order book: HPP ("High-Performance Polymers") orders already in excess of 2011 HPP sales • Capital expansion plan announced to support anticipated volume growth

http://www.investegate.co.uk/Article.aspx?id=201203060700217381Y

Outlook Despite challenging economic conditions and volatility in the UK's financial markets in the second half of the year, 2011 was an encouraging year for the Group. The significant new capital raised through the Group's placing has strengthened the balance sheet and the directors will seek to accelerate the growth of the portfolio through increased deployment of capital in the most promising companies as they mature. Clearly, uncertainty in the economic climate presents challenges and none more so than in the funding and trading environment for early-stage developing businesses such as many of those in the Group's portfolio. However, against this backdrop, a number of these companies are launching products, generating revenues and taking advantage of the opportunities presented by the commercialisation of disruptive technologies. We believe the announcement following the year end that Oxford Nanopore, the Group's most valuable portfolio company, intends to launch products later in 2012 is a pivotal moment for both Oxford Nanopore and the Group and we look forward to updating shareholders on the company's progress later in the year. The directors believe that, as a result of its diverse and developing portfolio, strong cash position and proprietary access to a significant proportion of the UK's leading scientific innovation, the Group has a number of competitive advantages and is accordingly well-placed to deliver significant value for shareholders over the medium to long term.

Commenting on the Group's annual results, Alan Aubrey, Chief Executive Officer of IP Group, said: "2011 was a year of significant progress for the Group with the material strengthening of the Company's balance sheet, enabling us to step up the level of capital deployed in our portfolio companies. Despite continued economic uncertainty, this year the value of the Group's portfolio has increased, the Group's portfolio companies have raised significantly more new capital and the Group has recorded more realisations than in 2010. We continue to believe that innovation remains strategically important to the UK economy and that the Group is strongly placed to play a central role in helping commercialise UK innovation. Our most valuable portfolio company, Oxford Nanopore, recently announced that it intends to start selling a DNA sequencer the size of a USB memory stick for less than $900 this year. This marked a pivotal moment for both companies that further supports the Group's long-term strategy and exemplifies the quality of technology seen in our portfolio. Since the year end, the Group's quoted portfolio companies have seen a net increase in fair value of £10m. Our strong cash position coupled with the excellent progress being made across the portfolio gives us renewed confidence that the Group will generate significant long-term returns for shareholders."

IP Group Annual Results IP Group plc (LSE: IPO), the developer of intellectual property based businesses, today announces its annual results for the year ended 31 December 2011. Financial and operational highlights · Net assets increased to £221.6m (2010: £173.1m) · Successful completion of placing and open offer, realising gross proceeds of £55.0m · Net cash and deposits at 31 December 2011: £60.5m (2010: £21.5m) · Adjusted profit before tax of £0.5m (2010: £1.8m), excluding £6.0m reduction in fair value of Oxford Equity Rights asset (2010: £nil) · Widening of partnership with University of Oxford through strategic stake in Technikos LLP · Appointment of four new directors to the Board Portfolio highlights · Fair value of investment portfolio: £123.8m (2010: £110.0m) · More than doubled investment in portfolio companies to £14.3m (2010: £6.9m) · Portfolio realisations: £3.7m (2010: £2.7m) · Value of ten largest holdings: £89.0m (2010: £81.3m) · Group's portfolio companies raised in excess of £90.0m of new capital (2010: £40.0m) · Oxford Nanopore Technologies Limited completed £25.0m private financing · Tissue Regenix Group plc completed £25.0m placing Post year-end highlights · Oxford Nanopore to launch two revolutionary DNA sequencing machines, GridIONTM and MinIONTM during 2012 · Net increase in the fair value of the Group's holdings in quoted portfolio companies, excluding net investment, of £10.0m since 31 December 2011.

http://www.investegate.co.uk/Article.aspx?id=201203060700227389Y

Abcam, which makes antibodies for various medical applications, is not as well received by Tempus. Trading at a very high 24 times earnings and involved in what may be a pricey bid for a US firm, Tempus thinks leave for now.

6 March 2012 - Exillon Energy plc ("Exillon Energy", the "Company" or the "Group") (EXI.LN), a London listed independent oil producer with assets in two oil-rich regions of Russia, Timan-Pechora ("Exillon TP") and West Siberia ("Exillon WS"), is pleased to announce unaudited production data for the month of February 2012 ("the Period"). · Average daily production[1] for the Group was 11,584 bbl/day during the period. · Average daily production for Exillon TP was 3,103 bbl/day, and for Exillon WS it was 8,481 bbl/day during the period. · Peak daily production[2] for the Group was 12,106 bbl/day during the period. The Company expects to make the March production announcement by 15 April 2012.

http://www.investegate.co.uk/Article.aspx?id=201203060700237547Y

Successful Test Results of Fourth Development Well of the Phase-III Drilling Campaign in the Oil Producing Kharsang Field Jubilant is pleased to announce that KSG#61 (previously referred to as KPL-H), the fourth of the seven phase III development wells in the already oil producing Kharsang Field has successfully tested for oil and has been put into production at an initial gross rate of 70 barrels of oil per day. The well, which was proposed as an infill development well with the primary objective of appraising the C-50 and D-00 sands and the secondary objective of appraising the G-00, G-60 and H-00 sands, was spudded on 9 December 2011. It was successfully drilled to the target depth of 1,127 metres Measured Depth ("MD") on 5 January 2012 and was subsequently tested with the smaller capacity work-over rig. Based on the wireline log interpretation, mud log and formation pressure data from the Reservoir Dynamic Tester, the consortium identified two intervals for testing between 1,022.5 and 1,030 metres MD, and 1,016.5 and 1,018.5 metres MD both located in the lower-most H-00 reservoir sand. After detailed testing, these zones have been brought into production utilising artificial lift from a Sucker Rod Pump producing at a gross rate of around 70 barrels of oil per day of 28.84 API crude. In addition to the currently producing H-00 reservoir sands, four shallow potential oil bearing zones have also been identified totalling to about 18 metres of net pay in the G-60, D-00 and C-50 sands and these will be tested subsequently. GeoEnpro Petroleum Ltd., a joint venture of GeoPetrol and Jubilant Enpro (a member of the wider Jubilant Bhartia Group), is the operator of the Kharsang Field. Jubilant holds a 25% interest in the block through its subsidiary, Jubilant Energy (Kharsang) Pvt Ltd. The other members of the consortium are Oil India Ltd and GeoPetrol.

http://www.investegate.co.uk/Article.aspx?id=201203060700237551Y

"The Location Information System (LIS) - developed and standardised by IBS, BMW Group and Ubisense - is unique worldwide. The solution presents us with a vital unique selling point. We are absolutely delighted that BMW AG has completed implementation at Plant Oxford," says Dr. Klaus-Juergen Schroeder, Chief Executive Officer of IBS AG. Richard Green, CEO of Ubisense, said, "We are delighted to be working with BMW Group and IBS extending the frontiers of visibility and control to automotive manufacturing."